Scientists track experimental Drug's journey through the body
NCT ID NCT07247942
Summary
This early-stage study aimed to understand how the body breaks down and eliminates an experimental antibiotic called zidebactam. Eight healthy male volunteers received a single dose containing a tiny, safe amount of radioactive tracer to track the drug's path. Researchers measured how much of the drug left the body through urine and stool, and checked for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Unit Inc. 3402 Kinsman Boulevard Madison, Wisconsin 53704 USA
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.